Cargando…
Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus
Early reports indicate that metformin, a clinical drug administered to treat type 2 diabetes mellitus (T2DM), was found to be associated with a better prognosis of cancer. The objective of this study was retrospectively analyzed the effect of metformin on the outcomes of Chinese breast cancer patien...
Autores principales: | Hui, Tianli, Shang, Chao, Yang, Liu, Wang, Meiqi, Li, Ruoyang, Song, Zhenchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113316/ https://www.ncbi.nlm.nih.gov/pubmed/33976288 http://dx.doi.org/10.1038/s41598-021-89475-y |
Ejemplares similares
-
Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052)
por: Li, Ruoyang, et al.
Publicado: (2019) -
The effects of metformin in type 1 diabetes mellitus
por: Beysel, Selvihan, et al.
Publicado: (2018) -
Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus
por: Li, Ling, et al.
Publicado: (2020) -
Prognostic Impact of Progesterone Receptor Status in Chinese Estrogen Receptor Positive Invasive Breast Cancer Patients
por: Yao, Nan, et al.
Publicado: (2017) -
Metformin in Gestational Diabetes Mellitus
por: Reece, Sara Wilson, et al.
Publicado: (2014)